cryptocurrency benefits Top

Xinwangda: The subsidiary and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries. Xinwangda announced that the subsidiary Xinwangda Power and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries, and the two sides will carry out extensive and in-depth cooperation on research and development, mass production and market development of a series of new energy battery materials for solid-state batteries around their respective development strategies. The cooperation contents include the development of cathode materials for solid-state batteries, the development of electrolytes and related materials for solid-state batteries, the cooperative development of solid-state batteries and industrial cooperation.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.Huazhi Liquor Store: It is planned to distribute a cash dividend of 8.09 yuan for every 10 shares. Huazhi Liquor Store announced that the company's profit distribution plan for the first three quarters of 2024 has been approved by the shareholders' meeting. The company will distribute a cash dividend of RMB 8.09 to all shareholders for every 10 shares based on the existing total share capital of 417 million shares and the share capital of 408 million shares after 9,098,100 shares have been repurchased in the repurchase special securities account. The total amount of cash dividends actually distributed was 330 million. The distribution of rights and interests in date of record is December 19th, 2024, and the ex-dividend date is December 20th, 2024. This dividend does not involve bonus shares and capitalization of capital reserve.

Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Polish Prime Minister Tusk told French President Macron that even if Russia and Ukraine cease fire, Polish troops will not enter Ukraine.Daiwa raised Tesla's target price to $420.

The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.Market News: Little Red Book's net profit will exceed $1 billion in 2024.Cui Dongshu, Chenglian Branch: The head car companies that grew in the auto market this year showed stronger characteristics of their own brands. Cui Dongshu, secretary general of Chenglian Branch, issued a document saying that the national new energy passenger car market showed a continuous upward trend in 2024, with a penetration rate of 52% for the retail sales of 1.26 million vehicles in November. With the strong growth of the extension program at the beginning of the year, the scrapping and renewal and trade-in since August have promoted the explosive growth of the entry-level hybrid of economical electric vehicles, forming a good performance that new energy vehicles will become stronger and stronger in 2024. This year, the head car companies that have grown in the auto market are characterized by stronger independent brands. In particular, the new energy trend of traditional independent car companies has surpassed the new forces, and more and more students have become "three excellent students" with mixed, pure electric and all-round development.